迪哲医药：2020年期权激励99.11万股限售股将上市流通

Core Viewpoint - The announcement from Dize Pharmaceutical details the second tranche of the employee stock option plan, which involves the release of 991,073 shares, representing 0.21% of the company's total share capital [1] Group 1 - The shares being released are part of the 2020 employee stock option plan, specifically the second exercise period [1] - A total of 105 shareholders are involved in this share release [1] - The shares were registered on February 16, 2023, with a lock-up period of 36 months, set to be tradable starting February 24, 2026 [1] Group 2 - The company's total share capital has changed due to previous equity incentive plans and targeted issuances, currently standing at 464,633,342 shares as of the announcement date [1]